本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Impact Biomedical, Inc.

0.4197
+0.01714.25%
盘前0.4118-0.0079-1.88%05:27 EDT
成交量:94.93万
成交额:39.26万
市值:507.22万
市盈率:-0.18
高:0.4414
开:0.4190
低:0.4000
收:0.4026
数据加载中...
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

SEC问询函

Form CORRESP - Correspondence
2024/08/12

SEC问询函

Form CORRESP - Correspondence
2024/08/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

SEC问询函

Form CORRESP - Correspondence
2024/08/08

SEC问询函

Form CORRESP - Correspondence
2024/06/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/02/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/22

重要事件披露

Form 8-K - Current report
2023/11/21

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/17

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/10/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

SEC问询函

Form CORRESP - Correspondence
2023/08/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]